---
$id: https://graph.org.ai/products/commodity/51284102
$type: Product
source: UNSPSC
code: "51284102"
title: "Cefdaloxime"
class: "51284100"
classTitle: "Third generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cefdaloxime

**UNSPSC Code**: 51284102
**Class**: [Third generation cephalosporins](Third generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cephalosporin antibiotic with the molecular formula C14H15N5O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6856HDT30F, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-oxime but generally known as cefdaloxime, which bears US NIH Compound Identifier 9571072. European Medicines Agency schedules Cefdaloxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07385MIG. The term CEFDALOXIME is an International Non-Proprietary Name. CEFDALOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefdaloxime under HS 29419000 and SITC 54139. As of Q4 2014, CEFDALOXIME remains the US FDA Preferred Term for this commodity. Cefdaloxime bears US NLM identifiers UMLS ID C2699135 and NCI Concept Code C76161. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\O)C2NC(SC2)N)C(=C(C1)COC)C(=O)O.

